4-155214098-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000910.4(NPY2R):c.159C>T(p.Leu53Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00497 in 1,613,992 control chromosomes in the GnomAD database, including 356 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.026 ( 178 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 178 hom. )
Consequence
NPY2R
NM_000910.4 synonymous
NM_000910.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.364
Publications
6 publications found
Genes affected
NPY2R (HGNC:7957): (neuropeptide Y receptor Y2) Predicted to enable calcium channel regulator activity and neuropeptide Y receptor activity. Involved in cardiac left ventricle morphogenesis and outflow tract morphogenesis. Located in cilium. Implicated in Huntington's disease; morbid obesity; and obesity. Biomarker of peripheral artery disease and temporal lobe epilepsy. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 4-155214098-C-T is Benign according to our data. Variant chr4-155214098-C-T is described in ClinVar as Benign. ClinVar VariationId is 776026.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.364 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0893 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NPY2R | NM_000910.4 | c.159C>T | p.Leu53Leu | synonymous_variant | Exon 2 of 2 | ENST00000329476.4 | NP_000901.1 | |
| NPY2R | NM_001370180.1 | c.159C>T | p.Leu53Leu | synonymous_variant | Exon 2 of 2 | NP_001357109.1 | ||
| NPY2R | NM_001375470.1 | c.159C>T | p.Leu53Leu | synonymous_variant | Exon 2 of 2 | NP_001362399.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NPY2R | ENST00000329476.4 | c.159C>T | p.Leu53Leu | synonymous_variant | Exon 2 of 2 | 1 | NM_000910.4 | ENSP00000332591.3 | ||
| NPY2R | ENST00000506608.1 | c.159C>T | p.Leu53Leu | synonymous_variant | Exon 2 of 2 | 1 | ENSP00000426366.1 | |||
| MAP9-AS1 | ENST00000630664.3 | n.399+39814C>T | intron_variant | Intron 2 of 4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0262 AC: 3979AN: 152132Hom.: 177 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3979
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00644 AC: 1620AN: 251464 AF XY: 0.00447 show subpopulations
GnomAD2 exomes
AF:
AC:
1620
AN:
251464
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00276 AC: 4035AN: 1461742Hom.: 178 Cov.: 32 AF XY: 0.00236 AC XY: 1718AN XY: 727172 show subpopulations
GnomAD4 exome
AF:
AC:
4035
AN:
1461742
Hom.:
Cov.:
32
AF XY:
AC XY:
1718
AN XY:
727172
show subpopulations
African (AFR)
AF:
AC:
3254
AN:
33474
American (AMR)
AF:
AC:
170
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
16
AN:
86252
European-Finnish (FIN)
AF:
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
AC:
20
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
205
AN:
1111880
Other (OTH)
AF:
AC:
370
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
207
414
620
827
1034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0262 AC: 3983AN: 152250Hom.: 178 Cov.: 32 AF XY: 0.0254 AC XY: 1892AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
3983
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
1892
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
3808
AN:
41532
American (AMR)
AF:
AC:
113
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5176
South Asian (SAS)
AF:
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23
AN:
68030
Other (OTH)
AF:
AC:
32
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
179
358
538
717
896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 21, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.